HCG Opens New Rs 129 Crore Oncology Center in Bengaluru

HEALTHCAREBIOTECH
Whalesbook Logo
AuthorIshaan Verma|Published at:
HCG Opens New Rs 129 Crore Oncology Center in Bengaluru
Overview

HealthCare Global Enterprises (HCG) has opened a new 132-bed oncology facility in Bengaluru's Hebbal area, investing Rs 129 crore. This expansion increases HCG's hospitals in the city to three and signals a focus on tech-driven cancer care.

Instant Stock Alerts on WhatsApp

Used by 10,000+ active investors

1

Add Stocks

Select the stocks you want to track in real time.

2

Get Alerts on WhatsApp

Receive instant updates directly to WhatsApp.

  • Quarterly Results
  • Concall Announcements
  • New Orders & Big Deals
  • Capex Announcements
  • Bulk Deals
  • And much more

HealthCare Global Enterprises (HCG), a leading oncology hospital chain, has inaugurated a new 132-bed facility in Bengaluru's Hebbal district. The expansion represents an investment of approximately Rs 129 crore.

Advanced Technology

This new center significantly boosts HCG's capacity in Bengaluru, bringing its total hospital count in the city to three. The facility is equipped with advanced diagnostic and treatment technology, including an MRI scanner integrated with a linear accelerator for precise, adaptive cancer therapy. HCG founder B S Ajaikumar noted the growing importance of data and technology in cancer care to effectively manage even advanced cases.

Strategic Growth

The launch follows private equity firm KKR's acquisition of a 54% stake in HCG for Rs 3,466 crore last year. HCG currently manages about 2,500 beds across 25 centers nationwide, with founder Ajaikumar and his family retaining a 10% holding.

Acquisition Discussions

Reports also suggest HCG is in talks to acquire American Oncology, currently owned by Siemens Healthineers, as the German company plans to divest. The new Hebbal facility includes five robotic-assisted operation theaters, 19 chemotherapy daycare beds, 14 premium treatment bays, and a 15-bed ICU. Comprehensive services offered include endoscopy, mammography, advanced laboratories, and histopathology.

Manish Mattoo, HCG's chief executive, highlighted the facility's commitment to patient-centric care, multidisciplinary expertise, and cutting-edge technology.

Get stock alerts instantly on WhatsApp

Quarterly results, bulk deals, concall updates and major announcements delivered in real time.

Disclaimer:This content is for educational and informational purposes only and does not constitute investment, financial, or trading advice, nor a recommendation to buy or sell any securities. Readers should consult a SEBI-registered advisor before making investment decisions, as markets involve risk and past performance does not guarantee future results. The publisher and authors accept no liability for any losses. Some content may be AI-generated and may contain errors; accuracy and completeness are not guaranteed. Views expressed do not reflect the publication’s editorial stance.